Clinical trial
A Multicenter, Randomized, Double-blind, Clinical Study to Investigate the Efficacy and Safety of Treatment With Tamsulosin 0.2mg Mono and Tamsulosin 0.2mg, Finasteride 5mg Combination Therapy in Patients With LUTS/BPH
NCT01736033 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-blind, Clinical Study to Investigate the Efficacy and Safety of Treatment With Tamsulosin 0.2mg Mono and Tamsulosin 0.2mg, Finasteride 5mg Combination Therapy in Patients With LUTS/BPH
- Lead sponsor
- Seoul National University Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- February 29, 2012
- Completion date
- June 30, 2017
- Enrollment
- 545 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
benign prostate hyperplasia